10-Q Filing

Company

Alzamend Neuro, Inc.

Filed

March 11, 2026

Period of Report

January 31, 2026

Accession Number

0001214659-26-003166

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →